Question-and-Answer Session
Operator
Thank you. (Operator Instructions) Our first question comes from the line Chuck Murphy with Sidoti and Co. Please proceed with your question.
Charles Murphy - Sidoti and Co.
Good afternoon, guys.
Richard J. Hipple - President, Chairman and CEO
Good afternoon.
Charles Murphy - Sidoti and Co.
I guess it's safe to say never a dull moment?
Richard J. Hipple - President, Chairman and CEO
Yeah, it seems to be that.
Charles Murphy - Sidoti and Co.
Just to check my facts here, you said media or ruthenium sales were $160 million for the full year?
John D. Grampa - SVP, CFO
Media.
Charles Murphy - Sidoti and Co.
Media.
John D. Grampa - SVP, CFO
It's just dominated by ruthenium.
Charles Murphy - Sidoti and Co.
Okay. Okay.
John D. Grampa - SVP, CFO
Today.
Charles Murphy - Sidoti and Co.
Okay. As far as your '08 sales guidance goes, what kind of contribution are you assuming there from the oxide layer?
John D. Grampa - SVP, CFO
In the 2008 plan?
Charles Murphy - Sidoti and Co.
Uhm.. uhm..
John D. Grampa - SVP, CFO
When you say contribution, Chuck, are you asking for profit information?
Charles Murphy - Sidoti and Co.
No, basically sales. How much in sales do you expect from the oxide layer in 2008?
John D. Grampa - SVP, CFO
I don't have that information in front of me. The ramp rate on oxide is not going to be unlike the ramp rate of ruthenium once it begins. The question becomes the timing of when it begins, and while we're reporting actuals to you as we move forward on ruthenium because of its significance, we'll begin to do that when oxide gets significant. But we will not share that level of detail on our business plan.
Charles Murphy - Sidoti and Co.
Okay. I guess I'm just trying to get a sense, you know, if ruthenium-type sales were $160 million in 2007 and you're saying that oxide could be a similar opportunity, at what point are we getting that $160 million?
Richard J. Hipple - President, Chairman and CEO
We have to be very careful, Chuck, because, you know, we get trapped in these you've got to stay away from revenue. It's really profit. That's what we're about here.
You've got totally different metals in the oxide layer than you do in the ruthenium layer, and it's a different dynamic. I mean, sales revenue, if a target's not a target, it's not a target. You've got different material sets and the, you know, the oxide targets don't have the same metal constituencies as the ruthenium targets.
- To read the full transcript on Seeking Alpha, click here »
